Literature DB >> 33456589

Invasive Treatment Options for Gastro-Esophageal Reflux Disease.

Vlad Dumitru1,2, Petre Hoara1,2, Daniela Dumitru1,2, Rodica Birla1,2, Cristina Gindea1,2, Silviu Constantinoiu1,2.   

Abstract

Reflux disease continues to be one of the most common pathologies in the world. There is much discussion regarding the mechanism of developing and the variety of possible symptoms. In recent years, the use of new technologies, like high-resolution manometry and pH impedance, brought new insights into this disease. Also, there are emerging therapies that are covering the gap between the patients treated with proton-pump inhibitor (PPI) therapy and those who benefit the most from laparoscopic treatment (hiatal hernia, complications of gastroesophageal reflux disease (GERD). Also, most of them are less invasive than a laparoscopic fundoplication. We present a short review of the treatment options in patients who need more than lifestyle changes and PPI therapy. ©Carol Davila University Press.

Entities:  

Keywords:  GERD; Invasive; treatment

Year:  2020        PMID: 33456589      PMCID: PMC7803320          DOI: 10.25122/jml-2020-0160

Source DB:  PubMed          Journal:  J Med Life        ISSN: 1844-122X


  40 in total

1.  Circumferential EMR of carcinoma arising in Barrett's esophagus: case report.

Authors:  Hitoshi Satodate; Haruhiro Inoue; Tatsuya Yoshida; Shinsuke Usui; Michiaki Iwashita; Norio Fukami; Akira Shiokawa; Shin-ei Kudo
Journal:  Gastrointest Endosc       Date:  2003-08       Impact factor: 9.427

2.  Comorbidity of aerophagia in GERD patients: outcome of laparoscopic antireflux surgery.

Authors:  T Kamolz; T Bammer; F A Granderath; R Pointner
Journal:  Scand J Gastroenterol       Date:  2002-02       Impact factor: 2.423

3.  Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.

Authors:  S B Clayton; C C Rife; E R Singh; J H Kalbfleisch; D O Castell
Journal:  Dis Esophagus       Date:  2012-01-31       Impact factor: 3.429

4.  Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.

Authors:  L Lundell; P Miettinen; H E Myrvold; S A Pedersen; B Liedman; J G Hatlebakk; R Julkonen; K Levander; J Carlsson; M Lamm; I Wiklund
Journal:  J Am Coll Surg       Date:  2001-02       Impact factor: 6.113

Review 5.  New Minimally Invasive Endoscopic and Surgical Therapies for Gastroesophageal Reflux Disease (GERD).

Authors:  Alexandru Eugen Nicolau; Adrian Lobonţiu; Silviu Constantinoiu
Journal:  Chirurgia (Bucur)       Date:  2018 Jan-Feb

6.  Evaluation of clinical outcome after laparoscopic antireflux surgery in clinical practice: still a controversial issue.

Authors:  Sandro Contini; Carmelo Scarpignato
Journal:  Minim Invasive Surg       Date:  2011-09-11

7.  Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study.

Authors:  Haruhiro Inoue; Hiroaki Ito; Haruo Ikeda; Chiaki Sato; Hiroki Sato; Chainarong Phalanusitthepha; Bu'Hussain Hayee; Nikolas Eleftheriadis; Shin-Ei Kudo
Journal:  Ann Gastroenterol       Date:  2014

8.  Transoral incisionless fundoplication with an ultrasonic surgical endostapler for the treatment of gastroesophageal reflux disease: 12-month outcomes.

Authors:  Pier Alberto Testoni; Sabrina Testoni; Giorgia Mazzoleni; Giuseppe Pantaleo; Maria Bernadette Cilona; Giovanni Distefano; Lorella Fanti; Mario Antonelli; Sandro Passaretti
Journal:  Endoscopy       Date:  2020-03-18       Impact factor: 10.093

9.  Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device.

Authors:  Hong Joo Kim; Chang-Il Kwon; William R Kessler; Don J Selzer; Gail McNulty; Amol Bapaye; Luigi Bonavina; Glen A Lehman
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

10.  Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up.

Authors:  Suyu He; Fei Xu; Xin Xiong; Hui Wang; Lipeng Cao; Ninglin Liang; Hanmei Wang; Xiaojuan Jing; Tianyu Liu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.